Consonance-HFW Acquisition Corp (Nasdaq: CHFW) is a healthcare-focused special purpose acquisition company sponsored by Consonance Capital Management, a New York-based investment firm with deep roots in healthcare and life sciences investing. The SPAC completed its initial public offering in 2020 and, as of its definitive proxy filing (DEFM14A) submitted on July 15, 2021, had reached an advanced stage in the shareholder approval process for a proposed business combination. The DEFM14A filing, carrying accession number 0001193125-21-216448, reflects the company's active pursuit of a healthcare sector target consistent with its sponsor's domain expertise. Sign up on SpacDesk for full filing history, sponsor profiles, and real-time deal tracking on CHFW and hundreds of other SPACs.